Back to discover
Drug
Barium
In clinical developmentEmerging researchEarly-to-mid development
Also known as Ba, Ba - Barium.
1
Research papers
1
Active clinical trials
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this drug.
Cough, Expiratory Training, and Chronic Aspiration After Head and Neck Radiotherapy
Clinical trial2026-04-16Results expected Q1 2027 · ClinicalTrials.gov
Clinical trial2015-12-01Withdrawn · ClinicalTrials.gov
Research1995-04-01The Journal of neuroscience : the official journal of the Society for Neuroscience
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Canonical name
Barium
Aliases & brands
BaBa - Barium
RxNorm CUI
1311067
ChEMBL ID
CHEMBL4297653
UNII
24GP945V5T
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY2
registered trials across all phases
1
Active studies
1
Late-stage (III+)
1
Discontinued
PHASE DISTRIBUTIONn = 2
Phase 1 / 21Phase N / A1
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Most influential
Major research themes1
omega-Conotoxins1
Journals, researchers & institutions
Top journals
- The Journal of neuroscience : the official journal of the Society for Neuroscience1
Leading researchers
- Randall A1
- Tsien RW1
Leading institutions
free-text, unnormalised
- Beckman Center1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
References & data sources
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials